Not all individuals with CLL need therapy. Even with all recent innovations, the iwCLL continue to suggests watchful observation for people with asymptomatic illness.86 This suggestion relies on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Each trials concluded that early https://ralpho530jtb9.blogpixi.com/profile